Mutation analysis of genes that control the GI/S cell cycle in melanoma: TP53, CDKNIA, CDKN2A, and CDKN2B

José Luis Soto, Carmen M. Cabrera, Salvio Serrano, Miguel Ángel López-Nevot

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Background: The role of genes involved in the control of progression from the G1 to the S phase of the cell cycle in melanoma tumors in not fully known. The aim of our study was to analyse mutations in TP53, CDKN1A, CDKN2A, and CDKN2B genes in melanoma tumors and melanoma cell lines Methods: We analysed 39 primary and metastatic melanomas and 9 melanoma cell lines by singlestranded conformational polymorphism (SSCP). Results: The single-stranded technique showed heterozygous defects in the TP53 gene in 8 of 39 (20.5%) melanoma tumors: three new single point mutations in intronic sequences (introns 1 and 2) and exon 10, and three new single nucleotide polymorphisms located in introns 1 and 2 (C to T transition at position 11701 in intron 1; C insertion at position 11818 in intron 2; and C insertion at position 11875 in intron 2). One melanoma tumor exhibited two heterozygous alterations in the CDKN2A exon 1 one of which was novel (stop codon, and missense mutation). No defects were found in the remaining genes. Conclusion: These results suggest that these genes are involved in melanoma tumorigenesis, although they may be not the major targets. Other suppressor genes that may be informative of the mechanism of tumorigenesis in skin melanomas should be studied. © 2005 Soto et al; licensee BioMed Central Ltd.
Original languageAmerican English
JournalBMC Cancer
DOIs
StatePublished - 8 Apr 2005
Externally publishedYes

Fingerprint Dive into the research topics of 'Mutation analysis of genes that control the GI/S cell cycle in melanoma: TP53, CDKNIA, CDKN2A, and CDKN2B'. Together they form a unique fingerprint.

  • Cite this